Cite
HARVARD Citation
Gnant, M. et al. (2019). Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet oncology. 20 (3), pp. 339-351. [Online].